Aortic aneurysm market seen rising to $6.62 billion by 2030

The global aortic aneurysm market is projected to grow from $4.06 billion in 2025 to $6.62 billion by 2030, according to a new report from The Business Research Company. Growth is being driven by aging populations, more cardiovascular disease, wider screening, and expanding use of minimally invasive repair techniques.

Why it matters: - The aortic aneurysm market is expanding as healthcare systems diagnose more cases and shift toward less invasive treatment options. - Faster market growth could increase demand for vascular devices, imaging tools, and post-treatment monitoring services. - The report points to earlier screening and AI-assisted diagnosis as forces that may change how aneurysms are found and treated.

What happened: - The Business Research Company released a global aortic aneurysm market report on Oct. 30, 2026. - The report estimates the market at $4.06 billion in 2025 and $4.47 billion in 2026. - The report forecasts the market will reach $6.62 billion by 2030. - The report projects a 10.0% CAGR from 2025 to 2026 and a 10.3% CAGR from 2026 to 2030. - A free sample of the report is available here. - The full report is available here.

The details: - Aortic aneurysms are bulges or ballooning in the wall of the aorta, the main artery that carries blood from the heart through the chest and abdomen. - Inherited genetic factors, certain health conditions, and pressure on artery walls can weaken the aorta and lead to aneurysm formation. - The report says the market’s recent growth has been supported by an aging population, higher cardiovascular disease rates, advances in diagnostic imaging, broader access to vascular surgeries, and greater use of surgical repair methods. - The report expects demand to rise for minimally invasive cardiovascular procedures, advanced vascular devices, expanded screening programs, AI-powered diagnostic tools, and improved patient-outcome optimization. - The report identifies wider use of endovascular aneurysm repair, or EVAR, as a major trend. - Other listed trends include advanced imaging for early diagnosis, personalized surgical planning, innovation in endovascular devices, and stronger post-treatment monitoring. - The report says rising alcohol and tobacco use is adding to the disease burden by weakening arterial walls and increasing the risk of aneurysm development. - Data from the Office for Health Improvement & Disparities in the UK show 310,863 adults aged 18 and older accessed drug and alcohol treatment services between April 2023 and March 2024, up 7% from 290,635 the year before.

Between the lines: - The report ties market growth to both disease prevalence and technology adoption, which suggests treatment spending is moving from reactive care toward earlier detection and more tailored intervention. - North America’s lead in 2025 points to the advantage of established healthcare infrastructure and wider access to advanced treatment. - The report’s emphasis on AI, EVAR, and imaging signals where vendors may compete next: earlier diagnosis, better precision, and less invasive procedures.

What's next: - The report expects market expansion to continue through 2030 at a double-digit pace. - Further growth is likely to depend on how quickly screening programs, imaging capabilities, and endovascular technologies spread across regions. - The report covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - The Business Research Company also says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables.

The bottom line: - Aortic aneurysm care is becoming a faster-growing treatment market, with demand increasingly shaped by earlier detection, minimally invasive repair, and broader adoption of advanced vascular technologies.